Data and implication based comparison of two chronic myeloid leukemia models
Chronic myeloid leukemia, a disorder of hematopoietic stem cells, is currently treated using targeted molecular therapy with imatinib. We compare two models that describe the treatment of CML, a multi-scale model (Model 1) and a simple cell competition model (Model 2).Both models describe the compet...
Saved in:
Main Authors: | R. A. Everett, Y. Zhao, K. B. Flores, Yang Kuang |
---|---|
Format: | Article |
Language: | English |
Published: |
AIMS Press
2013-07-01
|
Series: | Mathematical Biosciences and Engineering |
Subjects: | |
Online Access: | https://www.aimspress.com/article/doi/10.3934/mbe.2013.10.1501 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anuric Acute Kidney Injury in Chronic Myeloid Leukemia: A Rare Complication Case
by: Angela Kimberly Tjahjadi, et al.
Published: (2024-10-01) -
Clinical efficacy and safety of first‐line nilotinib or imatinib therapy in patients with chronic myeloid leukemia—Nationwide real life data
by: Petra Belohlavkova, et al.
Published: (2024-09-01) -
HSP90 inhibitors promote cell death by degrading Met and BCR::ABL1 in both imatinib-resistant and -sensitive chronic myeloid leukemia cells
by: Masanobu Tsubaki, et al.
Published: (2025-01-01) -
Isolated central nervous system relapse in blast crisis of chronic myeloid leukemia: a case report
by: Hari Priya Raghvan, et al.
Published: (2025-01-01) -
A rare vascular manifestation in chronic myeloid leukemia: a case report and literature review of Bier's spot development during nilotinib treatment
by: Ahmed Alsaati, et al.
Published: (2025-01-01)